These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6414105)

  • 1. Distribution and excretion of 2,3,6,2',3',6'- and 2,4,5,2',4',5'-hexachlorobiphenyl in senescent rats.
    Birnbaum LS
    Toxicol Appl Pharmacol; 1983 Sep; 70(2):262-72. PubMed ID: 6414105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and elimination of two sequential doses of 2,4,5,2',4',5'-hexachlorobiphenyl.
    Gallenberg LA; Vodicnik MJ
    Drug Metab Dispos; 1987; 15(3):363-6. PubMed ID: 2886312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
    Jondorf WR; Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1983; 11(6):597-601. PubMed ID: 6140146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat.
    Matthews HB; Anderson MW
    Drug Metab Dispos; 1975; 3(3):211-9. PubMed ID: 238820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue content as a modifier of the tissue distribution, biological effects, and excretion of a hexachlorobiphenyl in C57BL/6J and DBA/JBOMf mice.
    Ahotupa M; Mäntylä E
    Mol Pharmacol; 1983 Nov; 24(3):464-70. PubMed ID: 6415400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1982; 10(6):657-61. PubMed ID: 6130918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexabromonaphthalene contaminants of polybrominated biphenyls: chemical composition and disposition in the rat.
    Birnbaum LS; Darcey DJ; McKinney JD
    J Toxicol Environ Health; 1983; 12(4-6):555-73. PubMed ID: 6321745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound.
    Mühlebach S; Bickel MH
    Xenobiotica; 1981 Apr; 11(4):249-57. PubMed ID: 6795836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chlorination on the distribution and excretion of polychlorinated biphenyls.
    Mathews HB; Anderson MW
    Drug Metab Dispos; 1975; 3(5):371-80. PubMed ID: 241618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution, metabolism, and excretion of 2,4,4'-trichlorobiphenyl (CB-28) in the rat.
    Moir D; Viau A; Chu I; Wehler EK; Mörck A; Bergman A
    Toxicol Ind Health; 1996; 12(1):105-21. PubMed ID: 8713718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and biliary excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in the rhesus monkey (Macaca mulatta).
    Norback DH; Mack E; Reddy G; Britt J; Hsia MT
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):71-85. PubMed ID: 6794118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 1,2,3,7,8-pentachlorodibenzofuran in the rat.
    Brewster DW; Birnbaum LS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):490-8. PubMed ID: 3188012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chlorine substitution on the disposition of polychlorinated biphenyls following dermal administration.
    Garner CE; Demeter J; Matthews HB
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):157-67. PubMed ID: 16784763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chlorine position on the distribution and excretion of four hexachlorobiphenyl isomers.
    Matthews HB; Tuey DB
    Toxicol Appl Pharmacol; 1980 May; 53(3):377-88. PubMed ID: 6770494
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue distribution metabolism and excretion of 2,2',4,4',5-pentachlorodiphenyl ether in the rat.
    Komsta E; Chu I; Villeneuve DC; Benoit FM; Murdoch D
    Arch Toxicol; 1988; 62(4):258-62. PubMed ID: 3149180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1986; 14(3):361-5. PubMed ID: 2872039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition and the liver and thymus gland toxicity of 3,3',4,4'-tetrachlorobiphenyl in the female rat.
    Clarke DW; Brien JF; Racz WJ; Nakatsu K; Marks GS
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1253-60. PubMed ID: 6439399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 2,2',3,3',6,6'-hexachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl by human hepatic microsomes.
    Schnellmann RG; Putnam CW; Sipes IG
    Biochem Pharmacol; 1983 Nov; 32(21):3233-9. PubMed ID: 6416258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of hexachlorobenzene in male beagles. Distribution, excretion, and pharmacokinetic model.
    Sundlof SF; Hansen LG; Koritz GD; Sundlof SM
    Drug Metab Dispos; 1982; 10(4):371-81. PubMed ID: 6126337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.